Published in Clin Vaccine Immunol on July 15, 2009
GK-1 improves the immune response induced by bone marrow dendritic cells loaded with MAGE-AX in mice with melanoma. J Immunol Res (2014) 1.48
Heterologous prime-boost oral immunization with GK-1 peptide from Taenia crassiceps cysticerci induces protective immunity. Clin Vaccine Immunol (2011) 0.80
The synthetic parasite-derived peptide GK1 increases survival in a preclinical mouse melanoma model. Cancer Biother Radiopharm (2013) 0.77
Transgenic papaya: a useful platform for oral vaccines. Planta (2017) 0.75
Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol (2008) 7.21
Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med (1994) 4.91
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev (2009) 2.89
Vaccine adjuvants revisited. Vaccine (2007) 1.69
Conditions that induce tolerance in mature CD4+ T cells. J Exp Med (1997) 1.45
Age-related decline in immunity: implications for vaccine responsiveness. Expert Rev Vaccines (2008) 1.38
Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur J Immunol (2005) 1.37
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today (2003) 1.29
Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]. Drugs (2008) 1.23
A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis. Gerontology (2003) 1.17
Immune regulation by self-reactive T cells is antigen specific. J Immunol (2004) 1.13
Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J (1998) 1.05
Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. Vaccine (1999) 1.03
Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med (2001) 1.02
Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis. Infect Immun (1999) 1.01
MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice. Vaccine (1996) 1.00
Cysticercosis: identification and cloning of protective recombinant antigens. J Parasitol (1996) 0.99
Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis. Infect Immun (2003) 0.97
Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects. Vaccine (2003) 0.92
A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine. Vaccine (2005) 0.86
Regulatory T cells inhibit protein kinase C theta recruitment to the immune synapse of naive T cells with the same antigen specificity. J Immunol (2006) 0.84
Whole-body analysis of T cell responses. Curr Opin Immunol (2003) 0.83
The influence of lipopolysaccharide content on the apparent B cell stimulating activity of anti-mu preparations. J Immunol Methods (1988) 0.81
Origin of regulatory T cells with known specificity for antigen. Nat Immunol (2002) 7.49
Neurocysticercosis is still prevalent in Mexico. Salud Publica Mex (2013) 2.04
Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol (2002) 1.81
The critical role of agrin in the hematopoietic stem cell niche. Blood (2011) 1.54
The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6. Gut (2009) 1.36
Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity. J Neurol (2004) 1.33
Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther (2011) 1.28
Spatial distribution of Taenia solium porcine cysticercosis within a rural area of Mexico. PLoS Negl Trop Dis (2008) 1.25
Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Trop Med Int Health (2006) 1.23
Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid. J Clin Microbiol (2010) 1.16
Immune regulation by self-reactive T cells is antigen specific. J Immunol (2004) 1.13
Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg (2010) 1.08
The genome project of Taenia solium. Parasitol Int (2005) 1.07
Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults. Pediatr Infect Dis J (2006) 1.06
Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series. BMC Neurol (2010) 1.05
Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine (2008) 0.99
The pros and cons of chemokines in tumor immunology. Trends Immunol (2012) 0.99
Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Vet Immunol Immunopathol (2004) 0.98
Neurocysticercosis, a persisting health problem in Mexico. PLoS Negl Trop Dis (2010) 0.98
Medical treatment for neurocysticercosis: drugs, indications and perspectives. Curr Top Med Chem (2008) 0.97
Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling. Eur J Immunol (2009) 0.96
Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections. Int J Biol Sci (2011) 0.95
PCR tools for the differential diagnosis of Taenia saginata and Taenia solium taeniasis/cysticercosis from different geographical locations. Diagn Microbiol Infect Dis (2002) 0.93
Population genetic structure of Taenia solium from Madagascar and Mexico: implications for clinical profile diversity and immunological technology. Int J Parasitol (2003) 0.91
Neurological events related to influenza A (H1N1) pdm09. Influenza Other Respir Viruses (2014) 0.90
Human neurocysticercosis: in vivo expansion of peripheral regulatory T cells and their recruitment in the central nervous system. J Parasitol (2011) 0.90
Control of murine Ly6C(high) monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6. Blood (2012) 0.90
Vaccines against cysticercosis. Curr Top Med Chem (2008) 0.90
Determining the burden of neurological disorders in populations living in tropical areas: who would be questioned? Lessons from a Mexican rural community. Neuroepidemiology (2011) 0.90
Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs. Vaccine (2005) 0.89
Neurocysticercosis: HP10 antigen detection is useful for the follow-up of the severe patients. PLoS Negl Trop Dis (2013) 0.89
Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations. Oncoimmunology (2012) 0.89
Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion. Blood (2011) 0.88
Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity. Microbes Infect (2006) 0.88
A new highly effective anticysticercosis vaccine expressed in transgenic papaya. Vaccine (2007) 0.88
Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clin Immunol (2005) 0.87
A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis. Microbes Infect (2006) 0.87
Taenia solium: characterization of a small heat shock protein (Tsol-sHSP35.6) and its possible relevance to the diagnosis and pathogenesis of neurocysticercosis. Exp Parasitol (2005) 0.86
Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine. Vaccine (2006) 0.85
Genetic diversity of Taenia solium cysticerci from naturally infected pigs of central Mexico. Vet Parasitol (2009) 0.85
Regulatory T cells inhibit protein kinase C theta recruitment to the immune synapse of naive T cells with the same antigen specificity. J Immunol (2006) 0.84
Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation. J Immunol (2011) 0.84
Brucella spp. lumazine synthase: a novel antigen delivery system. Vaccine (2005) 0.84
TH2 profile in asymptomatic Taenia solium human neurocysticercosis. Microbes Infect (2003) 0.83
New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis. Arch Med Res (2002) 0.83
Cysticerci drive dendritic cells to promote in vitro and in vivo Tregs differentiation. Clin Dev Immunol (2013) 0.83
The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse. Blood (2013) 0.82
Application of synthetic peptides to the diagnosis of neurocysticercosis. Trop Med Int Health (2003) 0.82
The dual face of central nervous system tuberculosis: a new Janus Bifrons? Tuberculosis (Edinb) (2013) 0.82
Differential diagnosis of Taenia saginata and Taenia solium infections: from DNA probes to polymerase chain reaction. Trans R Soc Trop Med Hyg (2002) 0.82
Apoptosis induced by gamma irradiation of Taenia solium metacestodes. Parasitol Res (2003) 0.81
Protective immunity against Taenia crassiceps murine cysticercosis induced by DNA vaccination with a Taenia saginata tegument antigen. Microbes Infect (2002) 0.81
Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes. PLoS One (2009) 0.81
Tolerance induction to self antigens by peripheral dendritic cells. Eur J Immunol (2002) 0.81
Agrin is required for survival and function of monocytic cells. Blood (2012) 0.80
Heterologous prime-boost oral immunization with GK-1 peptide from Taenia crassiceps cysticerci induces protective immunity. Clin Vaccine Immunol (2011) 0.80
Th1 and Th2 indices of the immune response in pigs vaccinated against Taenia solium cysticercosis suggest various host immune strategies against the parasite. Vet Immunol Immunopathol (2003) 0.79
Renewed hope for a vaccine against the intestinal adult Taenia solium. J Parasitol (2007) 0.79
Recombinant S3Pvac-phage anticysticercosis vaccine: Simultaneous protection against cysticercosis and hydatid disease in rural pigs. Vet Parasitol (2010) 0.78
Characterization of a spliced leader gene and of trans-spliced mRNAs from Taenia solium. Mol Biochem Parasitol (2002) 0.78
Genetic variation in the Cytb gene of human cerebral Taenia solium cysticerci recovered from clinically and radiologically heterogeneous patients with neurocysticercosis. Mem Inst Oswaldo Cruz (2013) 0.78
Human neurocysticercosis: immunological features involved in the host's susceptibility to become infected and to develop disease. Microbes Infect (2013) 0.78
Pattern Recognition by CD6: A Scavenger-Like Lymphocyte Receptor. Curr Drug Targets (2016) 0.78
Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine. PLoS One (2010) 0.78
Developing plant-based vaccines against neglected tropical diseases: where are we? Vaccine (2012) 0.77
Impact of Taenia solium neurocysticercosis upon endocrine status and its relation with immuno-inflammatory parameters. Int J Parasitol (2011) 0.77
Transgenic plants: a 5-year update on oral antipathogen vaccine development. Expert Rev Vaccines (2014) 0.77
CD4+ and CD19+ splenocytes undergo apoptosis during an experimental murine infection with Taenia crassiceps. Parasitol Res (2003) 0.77
Taenia solium: identification and preliminary characterization of a lipid binding protein with homology to the SEC14 catalytic domain. Exp Parasitol (2007) 0.77
Neurocysticercosis: local and systemic immune-inflammatory features related to severity. Med Microbiol Immunol (2011) 0.77
Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis. Vaccine (2012) 0.77